[Knowledge and perceptions of people living with HIV regarding adherence support mechanisms in treatment centers in the Plateau-Central region of Burkina Faso, November 2024].

Medecine tropicale et sante internationale Pub Date : 2025-05-12 eCollection Date: 2025-06-30 DOI:10.48327/mtsi.v5i2.2025.643
Wedminère Noélie Zoungrana-Yameogo, Dominique Hélène Laurel Yabre, Fidèle Bakiono, Toussaint Compaore, Arielle Rita Belem, David Kangoye, Christian Philippe Yonli, Ouo Mireille Coulibaly, Koiné Maxime Drabo
{"title":"[Knowledge and perceptions of people living with HIV regarding adherence support mechanisms in treatment centers in the Plateau-Central region of Burkina Faso, November 2024].","authors":"Wedminère Noélie Zoungrana-Yameogo, Dominique Hélène Laurel Yabre, Fidèle Bakiono, Toussaint Compaore, Arielle Rita Belem, David Kangoye, Christian Philippe Yonli, Ouo Mireille Coulibaly, Koiné Maxime Drabo","doi":"10.48327/mtsi.v5i2.2025.643","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Since the introduction of antiretroviral therapy for HIV in Burkina Faso, several treatment adherence support mechanisms have been implemented to improve outcomes and prevent resistance. Our study aimed to evaluate the knowledge and perceptions of people living with HIV (PLHIV) regarding these mechanisms in the Plateau-Central region.</p><p><strong>Methods: </strong>We conducted a descriptive study in the Plateau-Central region, which is one of the 13 regions of Burkina Faso. PLHIV were selected as they arrived for their follow-up visits. Information was collected through interviews using a standardized questionnaire. Adherence was calculated based on the participants' reports. Those who took all their medications in the month prior to the survey were considered adherent. Quantitative variables were calculated using the averages, and qualitative variables were calculated using proportions.</p><p><strong>Results: </strong>A total of 347 PLHIV were included in the study. Of these, 69% were women, with a mean age of 45.6 ± 12.2 years. The mean treatment follow-up duration was 8.6 ± 5 years. Eighty percent of individuals adhered to treatment (95% CI [75-84]). Nearly all PLHIV (99.7%) were aware of adherence support mechanisms. The most well-known mechanisms were six-month antiretroviral drug supplies (RAVI6M) (71%), discussion groups (69.9%), individual discussion (69.9%), and counseling (64.2%).The recently introduced community-based antiretroviral drug refilling program outside of health facilities was less well known (42.2%). The most commonly used measures were face-to-face discussion (64%), counseling (62%), and RAVI6M (61.7%). The most appreciated measures were the six-month supply of antiretroviral drugs (44.6%), drug counting (10.7%), and patient interview (10.1%).</p><p><strong>Conclusion: </strong>PLHIV are familiar with and appreciate adherence support measures. The most appreciated measure is six-monthly refills of ARV drugs. Community-based ARV supply policies should be encouraged.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308576/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medecine tropicale et sante internationale","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48327/mtsi.v5i2.2025.643","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/30 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Since the introduction of antiretroviral therapy for HIV in Burkina Faso, several treatment adherence support mechanisms have been implemented to improve outcomes and prevent resistance. Our study aimed to evaluate the knowledge and perceptions of people living with HIV (PLHIV) regarding these mechanisms in the Plateau-Central region.

Methods: We conducted a descriptive study in the Plateau-Central region, which is one of the 13 regions of Burkina Faso. PLHIV were selected as they arrived for their follow-up visits. Information was collected through interviews using a standardized questionnaire. Adherence was calculated based on the participants' reports. Those who took all their medications in the month prior to the survey were considered adherent. Quantitative variables were calculated using the averages, and qualitative variables were calculated using proportions.

Results: A total of 347 PLHIV were included in the study. Of these, 69% were women, with a mean age of 45.6 ± 12.2 years. The mean treatment follow-up duration was 8.6 ± 5 years. Eighty percent of individuals adhered to treatment (95% CI [75-84]). Nearly all PLHIV (99.7%) were aware of adherence support mechanisms. The most well-known mechanisms were six-month antiretroviral drug supplies (RAVI6M) (71%), discussion groups (69.9%), individual discussion (69.9%), and counseling (64.2%).The recently introduced community-based antiretroviral drug refilling program outside of health facilities was less well known (42.2%). The most commonly used measures were face-to-face discussion (64%), counseling (62%), and RAVI6M (61.7%). The most appreciated measures were the six-month supply of antiretroviral drugs (44.6%), drug counting (10.7%), and patient interview (10.1%).

Conclusion: PLHIV are familiar with and appreciate adherence support measures. The most appreciated measure is six-monthly refills of ARV drugs. Community-based ARV supply policies should be encouraged.

Abstract Image

Abstract Image

Abstract Image

[2024年11月,布基纳法索高原-中部地区治疗中心艾滋病毒感染者关于依从性支持机制的知识和看法]。
导论:自布基纳法索采用抗逆转录病毒治疗艾滋病毒以来,已经实施了若干治疗依从性支持机制,以改善结果并预防耐药性。我们的研究旨在评估高原-中部地区艾滋病毒感染者(PLHIV)对这些机制的认识和看法。方法:我们在布基纳法索13个地区之一的高原-中部地区进行了描述性研究。在他们到达时被选中进行随访。通过使用标准化问卷的访谈收集信息。依从性是根据参与者的报告来计算的。那些在调查前一个月服用了所有药物的人被认为是坚持服用的。定量变量用平均值计算,定性变量用比例计算。结果:共纳入347例PLHIV。其中69%为女性,平均年龄为45.6±12.2岁。平均治疗随访时间8.6±5年。80%的个体坚持治疗(95% CI[75-84])。几乎所有的hiv感染者(99.7%)都知道依从性支持机制。最著名的机制是六个月抗逆转录病毒药物供应(RAVI6M)(71%)、小组讨论(69.9%)、个人讨论(69.9%)和咨询(64.2%)。最近在卫生设施之外实施的以社区为基础的抗逆转录病毒药物补充规划鲜为人知(42.2%)。最常用的措施是面对面讨论(64%)、咨询(62%)和RAVI6M(61.7%)。最受欢迎的措施是6个月抗逆转录病毒药物供应(44.6%)、药物计数(10.7%)和患者面谈(10.1%)。结论:hiv感染者对支持措施的依从性较为熟悉和满意。最受欢迎的措施是每六个月补充一次抗逆转录病毒药物。应鼓励以社区为基础的抗逆转录病毒药物供应政策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信